,Chapter 1: Indications for Pulmonary Function Testing Test
Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the
names he gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure
lung volumes ( see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
,3. The main gindication gfor gthe gmeasurement gof glung gvolumes gis gto gdo gwhich
gof gthe gfollowing?
a. Diagnose gor gassess gthe g severity g of grestriction.
b. Evaluate g the g severity g of g pulmonary g hypertension.
c. Determine gthe g level g of gcardiopulmonary g fitness.
d. Assess g the g risk g of g abdominal g surgical g procedures.
ANS: gA
The g most g common g reason g for g measuring g lung g volumes g is g to g identify
g restrictive glung gdisease. gDIF: 1 REF: g p. g35
g OBJ: EL-2 g MSC: gNBRC: gNone
4. DLCO gmeasurements gmay gbe gindicated gto gevaluate gpulmonary ginvolvement
gin gwhich gof gthe gfollowing gsystemic gdiseases?
a. Asthma
b. Sarcoidosis
c. Exertional ghypoxemia
, Stuvia.com g- gThe gMarketplace gto gBuy gand gSell gyour gStudy gMaterial
d. Guillain-Barré g syndrome
ANS: gB
Sarcoidosis gis gthe gonly gsystemic gdisease glisted gthat gaffects
ggas gexchange. gDIF: g1 gREF: gp. g9 g| gp. g19 g| gp. g21 g| gp.
g35 gOBJ: gEL-2 gMSC: gNBRC: gNone
5. Blood ggas ganalysis gis gused gwith gpatients gwith gCOPD
gto gdo gwhich gof gthe gfollowing?
a. Monitor g airway g responsiveness.
b. Determine glevel gof gcardiopulmonary g fitness.
c. Detect g pulmonary g hypertension.
d. Assess g need g for g supplementary g O2.
ANS: g D
Blood ggas ganalysis gis gmost gcommonly gused gto gdetermine gthe gneed gfor
gsupplemental goxygen gand gto gmanage gpatients gwho grequire gventilatory
gsupport.
DIF: 2 REF: g p. g15 g OBJ:
g EL- g1 gMSC: gNBRC: gCPFT g2A-2
6. Which gof gthe g following gcause g emphysema?
1. 1- gAntitrypsin gdeficiency
2. Exposure g to g environmental g pollutants
3. Radiation gtherapy
4. Cigarette g smoking
a. 1 g and g 2
b. 3 g and g 4
c. 1 g, g2, gand g 4
d. 2 g, g3, gand g 4
ANS: gC
Emphysema g is g caused g primarily g by g cigarette g smoking. g Some g emphysema
g is gcaused gby gthe gabsence gof ga gprotective genzyme. gChronic gexposure gto
genvironmental gpollutants gcan galso gcontribute gto gthe gdevelopment gof
gemphysema.
DIF: 1 REF: g p. g11 g OBJ: g EL-3 g| gAL-2 gMSC: gNBRC: gNone
7. An gadult gpatient gcomplains gof gchest gtightness gand gcough gwhenever ghe
gjogs gin gcold gweather. gThese gsymptoms gare gconsistent gwith gwhich gof gthe
gfollowing?
a. Cystic gfibrosis
b. Asthma
c. Pulmonary g hypertension
d. Idiopathic g pulmonary g fibrosis
|
Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the
names he gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure
lung volumes ( see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
,3. The main gindication gfor gthe gmeasurement gof glung gvolumes gis gto gdo gwhich
gof gthe gfollowing?
a. Diagnose gor gassess gthe g severity g of grestriction.
b. Evaluate g the g severity g of g pulmonary g hypertension.
c. Determine gthe g level g of gcardiopulmonary g fitness.
d. Assess g the g risk g of g abdominal g surgical g procedures.
ANS: gA
The g most g common g reason g for g measuring g lung g volumes g is g to g identify
g restrictive glung gdisease. gDIF: 1 REF: g p. g35
g OBJ: EL-2 g MSC: gNBRC: gNone
4. DLCO gmeasurements gmay gbe gindicated gto gevaluate gpulmonary ginvolvement
gin gwhich gof gthe gfollowing gsystemic gdiseases?
a. Asthma
b. Sarcoidosis
c. Exertional ghypoxemia
, Stuvia.com g- gThe gMarketplace gto gBuy gand gSell gyour gStudy gMaterial
d. Guillain-Barré g syndrome
ANS: gB
Sarcoidosis gis gthe gonly gsystemic gdisease glisted gthat gaffects
ggas gexchange. gDIF: g1 gREF: gp. g9 g| gp. g19 g| gp. g21 g| gp.
g35 gOBJ: gEL-2 gMSC: gNBRC: gNone
5. Blood ggas ganalysis gis gused gwith gpatients gwith gCOPD
gto gdo gwhich gof gthe gfollowing?
a. Monitor g airway g responsiveness.
b. Determine glevel gof gcardiopulmonary g fitness.
c. Detect g pulmonary g hypertension.
d. Assess g need g for g supplementary g O2.
ANS: g D
Blood ggas ganalysis gis gmost gcommonly gused gto gdetermine gthe gneed gfor
gsupplemental goxygen gand gto gmanage gpatients gwho grequire gventilatory
gsupport.
DIF: 2 REF: g p. g15 g OBJ:
g EL- g1 gMSC: gNBRC: gCPFT g2A-2
6. Which gof gthe g following gcause g emphysema?
1. 1- gAntitrypsin gdeficiency
2. Exposure g to g environmental g pollutants
3. Radiation gtherapy
4. Cigarette g smoking
a. 1 g and g 2
b. 3 g and g 4
c. 1 g, g2, gand g 4
d. 2 g, g3, gand g 4
ANS: gC
Emphysema g is g caused g primarily g by g cigarette g smoking. g Some g emphysema
g is gcaused gby gthe gabsence gof ga gprotective genzyme. gChronic gexposure gto
genvironmental gpollutants gcan galso gcontribute gto gthe gdevelopment gof
gemphysema.
DIF: 1 REF: g p. g11 g OBJ: g EL-3 g| gAL-2 gMSC: gNBRC: gNone
7. An gadult gpatient gcomplains gof gchest gtightness gand gcough gwhenever ghe
gjogs gin gcold gweather. gThese gsymptoms gare gconsistent gwith gwhich gof gthe
gfollowing?
a. Cystic gfibrosis
b. Asthma
c. Pulmonary g hypertension
d. Idiopathic g pulmonary g fibrosis
|
